Research Solutions (NASDAQ:RSSS - Get Free Report) is projected to announce its Q4 2025 results after the market closes on Thursday, September 18th. Analysts expect Research Solutions to post earnings of $0.03 per share and revenue of $12.5090 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Thursday, September 18, 2025 at 5:00 PM ET.
Research Solutions Trading Up 2.4%
NASDAQ:RSSS traded up $0.08 during trading hours on Monday, hitting $3.37. The stock had a trading volume of 48,051 shares, compared to its average volume of 60,910. Research Solutions has a 1-year low of $2.32 and a 1-year high of $4.24. The business has a 50 day simple moving average of $2.91 and a two-hundred day simple moving average of $2.82. The company has a market cap of $109.39 million, a PE ratio of -24.07, a price-to-earnings-growth ratio of 3.66 and a beta of 0.66.
Institutional Trading of Research Solutions
Several large investors have recently bought and sold shares of RSSS. Topline Capital Management LLC acquired a new stake in shares of Research Solutions during the second quarter worth approximately $125,000. Acadian Asset Management LLC grew its position in shares of Research Solutions by 83.7% during the first quarter. Acadian Asset Management LLC now owns 87,327 shares of the company's stock worth $225,000 after buying an additional 39,789 shares in the last quarter. Finally, NewEdge Advisors LLC acquired a new stake in shares of Research Solutions during the first quarter worth approximately $71,000. Institutional investors and hedge funds own 33.60% of the company's stock.
About Research Solutions
(
Get Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Featured Stories

Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.